All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Polyarteritis Nodosa-15256984

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Detail
1	15256984	A1511G	X	X	Polyarteritis Nodosa	View
2	15256984	A1511T	X	X	Polyarteritis Nodosa	View
3	15256984	A1574T	X	X	Polyarteritis Nodosa	View
4	15256984	A1676T	X	X	Polyarteritis Nodosa	View
5	15256984	A1703C	X	X	Polyarteritis Nodosa	View
6	15256984	C1449A	X	X	Polyarteritis Nodosa	View
7	15256984	C1449T	X	X	Polyarteritis Nodosa	View
8	15256984	C1637G	X	X	Polyarteritis Nodosa	View
9	15256984	C1637T	X	X	Polyarteritis Nodosa	View
10	15256984	G1390A	X	X	Polyarteritis Nodosa	View
11	15256984	G1437A	X	X	Polyarteritis Nodosa	View
12	15256984	G1634A	X	X	Polyarteritis Nodosa	View
13	15256984	G1634T	X	X	Polyarteritis Nodosa	View
14	15256984	T1741C	X	X	Polyarteritis Nodosa	View
15	15256984	A1762T	BCP		Polyarteritis Nodosa	View
16	15256984	G1764A	BCP		Polyarteritis Nodosa	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.